Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marine Soret

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Radiology|September 1, 2017
A New Fire Hazard for MR Imaging Systems: Blankets-Case ReportAnne Bertrand, Sandrine Brunel, Marie-Odile Habert, et al.
Molecular Imaging and Biology|July 10, 2019
Dose Reduction in Brain [<sup>18</sup>F]FDG PET/MRI: Give It Half a ChanceMarine Soret, Eve Piekarski, Nathanaëlle Yeni, et al.
Plos One|October 8, 2019
Attenuation correction using 3D deep convolutional neural network for brain 18F-FDG PET/MR: Comparison with Atlas, ZTE and CT based attenuation correctionPaul Blanc-Durand, Maya Khalife, Brian Sgard, et al.
Clinics and Research in Hepatology and Gastroenterology|January 8, 2024
Enhanced therapeutic outcomes with atezolizumab-bevacizumab and SIRT combination compared to SIRT alone in unresectable HCC: A promising approach for improved survivalAmel Mejait, Charles Roux, Marine Soret, et al.
JMIR Research Protocols|July 22, 2022
Salivary Dysfunctions and Consequences After Radioiodine Treatment for Thyroid Cancer: Protocol for a Self-Controlled Study (START Study)Clémence Baudin, Charlotte Lussey-Lepoutre, Alice Bressand, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|June 22, 2024
Health-related quality of life and radioiodine therapy in thyroid cancer patients: a before-and-after studyAlix Legrand, Marie-Odile Bernier, Alice Bressand, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 18, 2023
[18F]FDG PET-MRI provides survival biomarkers in primary central nervous system lymphoma in the elderly: an ancillary study from the BLOCAGE trial of the LOC networkLaura Rozenblum, Damien Galanaud, Caroline Houillier, et al.
Neuro-Oncology|February 17, 2024
Interim FDG-PET improves treatment failure prediction in primary central nervous system lymphoma: An LOC network prospective multicentric studyLaura Rozenblum, Caroline Houillier, Amandine Baptiste, et al.
Thyroid : Official Journal of the American Thyroid Association|June 10, 2023
Dysfunction of the Salivary and Lacrimal Glands After Radioiodine Therapy for Thyroid Cancer: Results of the START Study After 6-Months of Follow-UpClémence Baudin, Alice Bressand, Camille Buffet, et al.
Clinical Neuroradiology|February 11, 2022
Hybrid [<sup>18</sup>F]-F-DOPA PET/MRI Interpretation Criteria and Scores for Glioma Follow-up After RadiotherapyMarc Bertaux, Arnaud Berenbaum, Anna-Luisa Di Stefano, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Radiology|September 1, 2017
A New Fire Hazard for MR Imaging Systems: Blankets-Case ReportAnne Bertrand, Sandrine Brunel, Marie-Odile Habert, et al.
Molecular Imaging and Biology|July 10, 2019
Dose Reduction in Brain [<sup>18</sup>F]FDG PET/MRI: Give It Half a ChanceMarine Soret, Eve Piekarski, Nathanaëlle Yeni, et al.
Plos One|October 8, 2019
Attenuation correction using 3D deep convolutional neural network for brain 18F-FDG PET/MR: Comparison with Atlas, ZTE and CT based attenuation correctionPaul Blanc-Durand, Maya Khalife, Brian Sgard, et al.
Clinics and Research in Hepatology and Gastroenterology|January 8, 2024
Enhanced therapeutic outcomes with atezolizumab-bevacizumab and SIRT combination compared to SIRT alone in unresectable HCC: A promising approach for improved survivalAmel Mejait, Charles Roux, Marine Soret, et al.
JMIR Research Protocols|July 22, 2022
Salivary Dysfunctions and Consequences After Radioiodine Treatment for Thyroid Cancer: Protocol for a Self-Controlled Study (START Study)Clémence Baudin, Charlotte Lussey-Lepoutre, Alice Bressand, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|June 22, 2024
Health-related quality of life and radioiodine therapy in thyroid cancer patients: a before-and-after studyAlix Legrand, Marie-Odile Bernier, Alice Bressand, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 18, 2023
[18F]FDG PET-MRI provides survival biomarkers in primary central nervous system lymphoma in the elderly: an ancillary study from the BLOCAGE trial of the LOC networkLaura Rozenblum, Damien Galanaud, Caroline Houillier, et al.
Neuro-Oncology|February 17, 2024
Interim FDG-PET improves treatment failure prediction in primary central nervous system lymphoma: An LOC network prospective multicentric studyLaura Rozenblum, Caroline Houillier, Amandine Baptiste, et al.
Thyroid : Official Journal of the American Thyroid Association|June 10, 2023
Dysfunction of the Salivary and Lacrimal Glands After Radioiodine Therapy for Thyroid Cancer: Results of the START Study After 6-Months of Follow-UpClémence Baudin, Alice Bressand, Camille Buffet, et al.
Clinical Neuroradiology|February 11, 2022
Hybrid [<sup>18</sup>F]-F-DOPA PET/MRI Interpretation Criteria and Scores for Glioma Follow-up After RadiotherapyMarc Bertaux, Arnaud Berenbaum, Anna-Luisa Di Stefano, et al.
Pageof 4